In bioprocess applications, poloxamers are used in cell culture media for their cell cushioning effects because their addition leads to less stressful shear conditions for cells in reactors, which will lead to market growth.
Market Size - USD 24.63 million in 2018, Market Growth - CAGR of 6.4%, Market Trends - Increasing adoption in the pharmaceutical industry.
According to the latest analysis, the Global Poloxamer Market is expected to reach USD 41.21 billion by the year 2027 in terms of value, growing at a CAGR of 6.4%. The varying length of polymer blocks gives rise to different polymers identified as 124, 188, 237, 338, and 407, among others, showing a slight difference in their properties. The size and structure of poloxamers assemblies and their adsorption properties have made them useful in many applications, including drug delivery, nanoparticle synthesis, cosmetics and emulsion formulation, effective dispersants for inks/pigments, and versatile anti-biofouling coatings, to name a few.
Poloxamers can be used to increase the water solubility of hydrophobic, oily substances or otherwise increase the miscibility of two substances with different hydrophobicities. Owing to this property, poloxamers are commonly used in industrial applications, cosmetics, and pharmaceuticals. They have also been evaluated for various drug delivery applications and were shown to sensitize drug-resistant cancers to chemotherapy. In bioprocess applications, poloxamers are used in cell culture media for their cell cushioning effects because their addition leads to less stressful shear conditions for cells in reactors.
Regionally, the Asia Pacific market is projected to be the chief revenue-generating market during the forecast period. This market is also anticipated to grow at the highest CAGR of 7.6% during the forecast years. Increasing microbiological activities in the biotechnological and research centers in the region is a key factor influencing the market growth.
Further key findings from the report suggest
For the purpose of this report, Reports and Data has segmented the Global Poloxamer Market on the basis of grade, method, application, end-use, and region:
Grade Outlook (Volume, Kilo Tons; Revenue, USD Million; 2017-2027)
Method Outlook (Volume, Kilo Tons; Revenue, USD Million; 2017-2027)
Application Outlook (Volume, Kilo Tons; Revenue, USD Million; 2017-2027)
End-Use Outlook (Volume, Kilo Tons; Revenue, USD Million; 2017-2027)
Regional Outlook (Volume, Kilo Tons; Revenue, USD Million; 2017-2027)
Reasons to Buy the Report
Market Size - USD 24.63 million in 2018, Market Growth - CAGR of 6.4%, Market Trends - Increasing adoption in the pharmaceutical industry.
According to the latest analysis, the Global Poloxamer Market is expected to reach USD 41.21 billion by the year 2027 in terms of value, growing at a CAGR of 6.4%. The varying length of polymer blocks gives rise to different polymers identified as 124, 188, 237, 338, and 407, among others, showing a slight difference in their properties. The size and structure of poloxamers assemblies and their adsorption properties have made them useful in many applications, including drug delivery, nanoparticle synthesis, cosmetics and emulsion formulation, effective dispersants for inks/pigments, and versatile anti-biofouling coatings, to name a few.
Poloxamers can be used to increase the water solubility of hydrophobic, oily substances or otherwise increase the miscibility of two substances with different hydrophobicities. Owing to this property, poloxamers are commonly used in industrial applications, cosmetics, and pharmaceuticals. They have also been evaluated for various drug delivery applications and were shown to sensitize drug-resistant cancers to chemotherapy. In bioprocess applications, poloxamers are used in cell culture media for their cell cushioning effects because their addition leads to less stressful shear conditions for cells in reactors.
Regionally, the Asia Pacific market is projected to be the chief revenue-generating market during the forecast period. This market is also anticipated to grow at the highest CAGR of 7.6% during the forecast years. Increasing microbiological activities in the biotechnological and research centers in the region is a key factor influencing the market growth.
Further key findings from the report suggest
- The grade 338 segment is expected to grow at a CAGR of 5.1% by 2027. The significant share is due to the use of this grade of the compound as surfactants in pharmaceuticals and personal care products. However, a CIR (Cosmetic Ingredient Review) Expert Panel evaluated and concluded that 338 grade, when consumed at 5.0 g/kg/day, produced slight transient diarrhea, whereas it produced no adverse effects at 0.2 or 1.0 g/kg/day.
- The emulsification method that utilizes poloxamers allows for lower processing temperatures. The drug and solubilizing agent form an oily phase, which is encapsulated by the poloxamer. Multi-layer particles can be easily manufactured with this method. For instance, by first creating a mixture of drugs with Tween 80 (poly (ethylene oxide) sorbitan monooleate) and soybean oil, more abundant, lipid-like aggregates can be formed and then these are encapsulated by poloxamer.
- Key participants include BASF, Anshul Life Sciences, DeWolf Chemicals, Solvay, Sirion Biotech Gmbh, BioPharm International, Sigma-Aldrich, Planet Science, SpecialChem.
- BASF is a key player in the poloxamer market. With a global presence in North America, Europe, Asia Pacific, South America, and Middle East & Africa, the company offers poloxamers by the name Kolliphor and Kollisolv. As of 2018, the company’s total revenue accounted for USD 73.9 billion.
For the purpose of this report, Reports and Data has segmented the Global Poloxamer Market on the basis of grade, method, application, end-use, and region:
Grade Outlook (Volume, Kilo Tons; Revenue, USD Million; 2017-2027)
- Poloxamer 68
- Poloxamer 88
- Poloxamer 98
- Poloxamer 108
- Poloxamer 124
- Poloxamer 188
- Poloxamer 237
- Poloxamer 338
- Poloxamer 407
Method Outlook (Volume, Kilo Tons; Revenue, USD Million; 2017-2027)
- Direct Solubilization
- Thin Film methods
- Temperature-induced emulsification
Application Outlook (Volume, Kilo Tons; Revenue, USD Million; 2017-2027)
- Biotechnological Activity
- Brain Injury Treatment
- DNA Delivery
- Microbiological Activity
- Cardiovascular Treatment
- Others
End-Use Outlook (Volume, Kilo Tons; Revenue, USD Million; 2017-2027)
- Pharmaceutical Industry
- Biotechnological Companies
- Research Centers
- Others
Regional Outlook (Volume, Kilo Tons; Revenue, USD Million; 2017-2027)
- North America
- U.S.
- Canada
- Europe
- Germany
- France
- U.K.
- Spain
- Italy
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Rest of Asia Pacific
- Latin America
- Brazil
- Middle East & Africa
Reasons to Buy the Report
- A robust analysis and estimation of the Poloxamer Market with four levels of quality check - in-house database, expert interviews, governmental regulation, and a forecast specifically done through time series analysis
- A holistic competitive landscape of the all the major players in the Poloxamer market. The report covers their market shares, strategic initiatives, new product launches, R&D expenditure, M&As, Joint ventures, expansionary plans, product wise metric space analysis and key developments
- Go-to-market strategies specifically formulated in line with location analysis which takes into the factors such as government regulations, supplier mapping, supply chain obstacles, and feedback from local vendors
- Most deep dive segmental bifurcation available currently in the market. Our stellar methodology helps us understand the overall gamut of the supply chain and will help you explain the current market dynamics
- Special focus given on vendor landscape, supplier portfolio, customer mapping, production capacity, and yearly capacity utilization
Table of Contents
Chapter 1. Market Synopsis
Chapter 2. Executive Summary
Chapter 4. Poloxamer Segmentation & Impact Analysis
Chapter 5. Poloxamer Market By Grade Insights & Trends
Chapter 6. Poloxamer Market By Method Insights & Trends
Chapter 7. Poloxamer Market By Application Insights & Trends
Chapter 8. Poloxamer Market By End-Use Insights & Trends
Chapter 9. Poloxamer Market Regional Outlook
Chapter 10. Competitive Landscape
Chapter 11. Company Profiles
Companies Mentioned
- BASF
- Anshul Life Sciences
- DeWolf Chemicals
- Solvay
- Sirion Biotech Gmbh
- BioPharm International
- Sigma-Aldrich
- Planet Science
- SpecialChem
